Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when BURU files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Restatement (new) — The company is restating its Q2 2026 financial statements due to a material accounting error.
Nuburu restates Q2 2026 financials after material error in Tekne note valuation
Filed September 16, 2026 · Period ending September 16, 2026 · ~1 min read
Key Changes
-
high
Board and management concluded Q2 2026 financial statements should no longer be relied upon and will be restated.
Item 4.02 verify on EDGAR → -
high
Error stemmed from using a €15.2M Tekne equity value instead of €25.4M to value the convertible note receivable.
Item 4.02 verify on EDGAR → -
medium
Restatement will increase assets by $761,001, reflecting a higher fair value for the Tekne note.
Item 4.02 verify on EDGAR →
Summary
Nuburu, Inc. announced that its previously issued unaudited condensed consolidated financial statements for the three and six months ended June 30, 2026, should no longer be relied upon. The Board of Directors and management, upon the recommendation of the Audit Committee, concluded that a material accounting error required a restatement.
The error involved the valuation of the Tekne Convertible Note Receivable, where the company used an incorrect equity value for Tekne, leading to an understatement of the note's fair value. The restatement will increase the company's assets by $761,001, reflecting the corrected fair value of the Tekne Convertible Note Receivable.
This adjustment flows through to the change in fair value of convertible notes receivable for the affected periods. The company determined the error was material under ASC Topic 250, triggering the restatement. For investors, this restatement raises concerns about the accuracy of the company's financial reporting and internal controls over valuation processes. The need to restate financial statements can undermine confidence in management's financial oversight and may lead to increased scrutiny from regulators or auditors. Investors should review the restated financials once filed and monitor for any further corrections or control deficiencies.
Section-by-Section Diff
Event · Item 4.02 — Non-Reliance on Previously Issued Financial Statements
Nuburu restates Q2 2026 financials after a material error in valuing its Tekne convertible note receivable.
Added in current filing · verify on EDGAR →
The Company determined that it had used a Tekne equity value of €15.2 million ($17.4 million) to value the Tekne Convertible Note Receivable as of June 30, 2026 instead of using the equity value of €25.4 million ($29.0 million)
The company used an incorrect equity value for Tekne when valuing the convertible note receivable, which led to the misstatement. The corrected value is higher, increasing the note's fair value.
Added in current filing · verify on EDGAR →
the fair value of the Tekne Convertible Note Receivable increased from €20,523,000 ($23,446,999) to €21,189,000 ($24,208,000), which was an increase of $761,001
The correction increased the fair value of the Tekne Convertible Note Receivable by $761,001, which flows through to the change in fair value of convertible notes receivable for the three and six months ended June 30, 2026.
Added in current filing · verify on EDGAR →
The accounting error was determined to be material.
The company determined the error was material, triggering the restatement under ASC Topic 250.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 2, 2026 · How we verify